This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Boron
- DrugBank Accession Number
- DB11203
- Background
Boron (B) is a chemical element with an atomic number 5 that belongs in the Period 2 and Group 13 in the periodic table. It is a low-abundant metalloid that is a poor electrical conductor at room temperature. Natural boron exists in 2 stable isotopes however pure boron is hard to prepare due to contamination by different elements. It is also found for applications including ceramics, high-hardness or abrasive compounds, metal coatings, detergents, bleaching agents, insecticides, semiconductors, magnets, wood preservatives, and an additive in glass fibers of boron-containing fiberglass for insulation and structural materials. Boric acid contains antiseptic, antifungal, and antiviral properties thus it is used as a water clarifier in swimming pool water treatment. There are few pharmaceutical agents that contain a boron molecule in their structures, such as Tavaborole and Bortezomib.
- Type
- Small Molecule
- Groups
- Experimental
- Structure
Structure for Boron (DB11203)
- Weight
- Average: 10.81
Monoisotopic: 11.009305 - Chemical Formula
- B
- Synonyms
- Bor
- Boracium
- Bore
- Boro
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Used as adjunct in combination to prevent Osteoporosis Combination Product in combination with: Cholecalciferol (DB00169), Calcium (DB01373) ••• ••• - Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image BIOGROW MIN Boron (500 mcg) + Calcium (15 mg) + Chromium (16.8 mcg) + Copper (100 mcg) + Iodine (33.5 mcg) + Iron (3 mg) + Lithium carbonate (117 mcg) + Magnesium (5 mg) + Manganese cation (700 mcg) + Molybdenum (12.6 mcg) + Nickel cation (67 mcg) + Phosphorus (2 mg) + Potassium (5 mg) + Selenium (16.7 mcg) + Silicon (12.5 mcg) + Vanadium (8.5 mcg) + Zinc (2 mg) Tablet, film coated Oral UNISON NUTRACEUTICALS SDN. BHD. 2020-09-08 Not applicable Malaysia 
BIOGROW® VITE Boron (50 mcg) + Ascorbic acid (25 mg) + Beta carotene (500 IU) + Biotin (50 mcg) + Bromelains (12.5 mg) + Calcium (2.25 mg) + Cholecalciferol (200 IU) + Choline (8.5 mg) + Chromium (10 mcg) + Copper (34 mcg) + Cyanocobalamin (2 mcg) + Folic acid (125 mcg) + Inositol (1.75 mg) + Iodine (56 mcg) + Iron (2 mg) + Magnesium (1.5 mg) + Manganese cation (750 mcg) + Molybdenum (9 mcg) + Nicotinamide (10 mg) + Pancrelipase amylase (12.5 mg) + Pantothenic acid (10 mg) + Papain (12.5 mg) + Phosphorus (2.5 mg) + Potassium (2.5 mg) + Pyridoxine (5 mg) + Riboflavin (2 mg) + Selenium (17 mcg) + Silicon (9 mcg) + Thiamine (2 mg) + Thiamine (2.5 mg) + Vanadium (4 mcg) + Vitamin A (2500 IU) + Vitamin E (15 IU) + Zinc (2 mg) Tablet Oral UNISON NUTRACEUTICALS SDN. BHD. 2020-09-08 Not applicable Malaysia Calcemin Boron (50 ug/1) + Previtamin D(3) (0.75 mg/1) + Zinc (2 mg/1) Tablet, film coated Oral Bayer Healthcare Llc. 2016-04-01 Not applicable US 
Calcemin Silver Boron (2.6 mg/1) + Magnesium oxide (40 mg/1) + Zinc oxide (7.5 mg/1) Tablet, film coated Oral Bayer Healthcare Llc. 2016-04-01 Not applicable US GNC Multivitamin Mega Women Tablet Boron (1 mg) + Ascorbic acid (100 mg) + Astaxanthin (25 mcg) + Biotin (150 mcg) + Calcium (250 mg) + Cholecalciferol (800 IU) + Choline (5 mg) + Chromium (60 mcg) + Copper (1 mg) + Cryptoxanthin (5 mcg) + Cyanocobalamin (25 mcg) + Folic acid (200 mcg) + Grape seed oil (0.5 mg) + Green tea leaf (7 mg) + Hyaluronic acid (0.5 mg) + Inositol (5 mg) + Iodine (75 mcg) + Iron (9 mg) + Lipoic acid (12.5 mg) + Lutein (1 mg) + Lycopene (0.5 mg) + Magnesium (25 mg) + Manganese cation (1 mg) + Molybdenum (37.5 mcg) + Niacin (25 mg) + Pantothenic acid (25 mg) + Phylloquinone (40 mcg) + Pyridoxine (25 mg) + Riboflavin (25 mg) + Selenium (100 mcg) + Silicon dioxide (2 mg) + Thiamine (25 mg) + Turmeric (250 mcg) + Vanadium (5 mcg) + Vitamin A (2500 IU) + Vitamin E (15 IU) + Zeaxanthin (200 mcg) + Zinc (7.5 mg) + gamma-Aminobutyric acid (0.5 mg) Tablet Oral GNC LIVEWELL MALAYSIA SDN. BHD. 2020-09-08 Not applicable Malaysia - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Calcium Folic Acid Plus D Chewable Boron (250 ug/1) + Calcium carbonate (1342 mg/1) + Cholecalciferol (300 [iU]/1) + Cyanocobalamin (125 ug/1) + Folic acid (1 mg/1) + Magnesium (50 mg/1) + Pyridoxine (10 mg/1) Wafer Oral Acella Pharmaceuticals, LLC 2009-03-20 2022-08-02 US Foliflex Boron (25 ug/1) + Ascorbic acid (250 mg/1) + Biotin (100 ug/1) + Calcium carbonate (75 mg/1) + Cholecalciferol (13.75 ug/1) + Chromium nicotinate (37.5 ug/1) + Cupric oxide (1 mg/1) + Cyanocobalamin (13 ug/1) + DL-alpha tocopheryl acetate (45 mg/1) + Ferrous fumarate (9 mg/1) + Folic acid (500 ug/1) + Magnesium oxide (37.5 mg/1) + Manganese sulfate (0.75 mg/1) + Molybdenum (25 ug/1) + Nicotinamide (22.5 mg/1) + Pantothenic acid (15 mg/1) + Potassium Iodide (25 ug/1) + Potassium chloride (24.5 mg/1) + Pyridoxine hydrochloride (6 mg/1) + Riboflavin (3.35 mg/1) + Selenium (30 ug/1) + Thiamine mononitrate (3.25 mg/1) + Vitamin A acetate (1500 ug/1) + Zinc oxide (15 mg/1) Tablet Oral PureTek Corporation 2021-10-25 Not applicable US Folitin-Z Boron (25 ug/1) + Ascorbic acid (250 mg/1) + Biotin (100 ug/1) + Calcium carbonate (75 mg/1) + Cholecalciferol (13.75 ug/1) + Chromium nicotinate (37.5 ug/1) + Cupric oxide (1 mg/1) + Cyanocobalamin (13 ug/1) + DL-alpha tocopheryl acetate (45 mg/1) + Ferrous fumarate (9 mg/1) + Folic acid (500 ug/1) + Magnesium oxide (37.5 mg/1) + Manganese sulfate (0.75 mg/1) + Molybdenum (25 ug/1) + Nicotinamide (22.5 mg/1) + Pantothenic acid (15 mg/1) + Potassium Iodide (25 ug/1) + Potassium chloride (24.5 mg/1) + Pyridoxine hydrochloride (6 mg/1) + Riboflavin (3.35 mg/1) + Selenium (30 ug/1) + Thiamine mononitrate (3.25 mg/1) + Vitamin A acetate (1500 ug/1) + Zinc oxide (15 mg/1) Tablet Oral PureTek Corporation 2021-02-11 Not applicable US Neonatal Plus Vitamin Boron (0.2 mg/1) + Ascorbic acid (20 mg/1) + Calcium (200 mg/1) + Cholecalciferol (10 ug/1) + Citrus bioflavonoids (2 mg/1) + Copper (2 mg/1) + Cyanocobalamin (12 ug/1) + Ferrous fumarate (27 mg/1) + Folic acid (1000 ug/1) + Inositol (5 mg/1) + Nicotinamide (20 mg/1) + Pyridoxine hydrochloride (10 mg/1) + Riboflavin (3 mg/1) + Thiamine chloride (1.84 mg/1) + Vitamin A (1200 ug/1) + Zinc oxide (25 mg/1) + alpha-Tocopherol acetate (9.2 mg/1) Tablet Oral Neomed Pharmaceutical 2018-07-31 Not applicable US Prenate Chewable Boron (250 ug/1) + Bilberry (25 mg/1) + Biotin (280 ug/1) + Calcium carbonate (500 mg/1) + Cholecalciferol (300 [iU]/1) + Cyanocobalamin (125 mg/1) + Folic acid (1 mg/1) + Magnesium oxide (50 mg/1) + Pyridoxine hydrochloride (10 mg/1) Tablet, chewable Oral Avion Pharmaceuticals, Llc 2013-01-16 Not applicable US
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of inorganic compounds known as homogeneous metalloid compounds. These are inorganic compounds containing only metal atoms,with the largest atom being a metalloid atom.
- Kingdom
- Inorganic compounds
- Super Class
- Homogeneous metal compounds
- Class
- Homogeneous metalloid compounds
- Sub Class
- Not Available
- Direct Parent
- Homogeneous metalloid compounds
- Alternative Parents
- Not Available
- Substituents
- Homogeneous metalloid
- Molecular Framework
- Not Available
- External Descriptors
- boron group element atom, nonmetal atom (CHEBI:27560)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- N9E3X5056Q
- CAS number
- 7440-42-8
- InChI Key
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N
- InChI
- InChI=1S/B
- IUPAC Name
- boranylidyne
- SMILES
- [B]
References
- General References
- Not Available
- External Links
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data3 Completed Treatment Radiodermatitis 1 somestatus stop reason just information to hide 2 Active Not Recruiting Treatment Advanced Malignant Solid Tumor / Recurrent Malignant Solid Neoplasm 1 somestatus stop reason just information to hide 1 Terminated Treatment Brain and Central Nervous System Tumors 1 somestatus stop reason just information to hide 1 Unknown Status Treatment Diabetic Foot Ulcers (DFUs) 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Capsule Oral Tablet, film coated Oral Wafer Oral Tablet Oral Tablet, chewable Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP 0.33 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 0 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 0 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 0 m3·mol-1 Chemaxon Polarizability 1.78 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at December 03, 2015 16:51 / Updated at September 28, 2021 21:54